Quest Diagnostics DGX
-
New Morningstar Analyst Report - Quest Diagnostics
… medium-term investment, Quest has not been able to capitalize ..... Indian diagnostics market. Quest Diagnostics is a leading independent ..... sustained over the next few years, Quest would face a prolonged period ..... profitability buckle under pressure. Quest Diagnostics has positioned itself as the …
-
IHF iShares Dow Jones US Healthcare Provider ETF Analysis, Report, Research, 5 Star Rating – Morningstar
… this index. And diagnostics services firms like Quest Diagnostics and Lab Corp. and hospital operators like Community ..... Medicare Advantage. Diagnostics firms such as Quest Diagnostics DGX and Lab Corp LH are facing headwinds of their own …
-
Quest Diagnostics' CEO Discusses Q1 2012 Results - Earnings Call Transcript
Quest Diagnostics ( DGX ) Q1 2012 Earnings Call April 18, 2012 8:30 am ET Executives Kathleen Valentine - Director ..... Fargo Securities, LLC, Research Division Erin Wilson Presentation Operator Welcome to the Quest Complete Story »
-
Quest Sees Solid Pricing and Volume in 1Q Driven by Acquisitions
Quest Diagnostics DGX kicked off 2012 with a strong first quarter ..... modestly to reflect cash flows realized. Quest saw solid revenue growth in the first ..... falling 2% in the first quarter-- Quest 's testing volume nonetheless increased …
-
Quest Diagnostics : Earnings Preview
By Zacks Investment Research : Quest Diagnostics ( DGX ) is scheduled to release its first quarter 2012 ..... Zacks Consensus Estimate. Fourth Quarter Recap Quest Diagnostics reported earnings of $1.19 per share in the …
-
Quest Diagnostics profit tops estimates
April 18 (Reuters) - Quest Diagnostics Inc , the No. 1 clinical laboratory-testing company, posted higher-than-expected quarterly profit, helped by an increase in testing volume.
-
Quest Diagnostics ( DGX ): Q1 EPS of $1.07 beats by $0.06. Revenue of $1.94B (+6.3% Y/Y) beats by $60M. (PR)
Quest Diagnostics ( DGX ): Q1 EPS of $1.07 beats by $0.06 . Revenue of $1.94B (+6.3% Y/Y) beats by $60M . ( PR ) Post your comment!
-
Quest Diagnostics , Inc. DGX Q1 2012 Earnings Call Transcript
Welcome to the Quest Diagnostics ' First Quarter 2012 Conference ..... are the copyrighted property of Quest Diagnostics , with all rights reserved. Any ..... the express written consent of Quest Diagnostics is strictly prohibited. Thank …
-
Epigenomics Enrolls First Participant In Its FIT Comparative Study With Epi proColon®
… validated through multiple partnerships with leading global diagnostic companies including Abbott, QIAGEN, Sysmex, and Quest Diagnostics . Epigenomics is an international company with operations in Europe and the U.S.A. The company recently announced …
-
New Morningstar Analyst Report - VCA Antech
… We find the hefty lab operating margins--close to 40%--extremely appealing. They're much better than Quest Diagnostics ' DGX human diagnostic operating margins of 17%. Finally, we like the cash-oriented nature of the pet health business …